ADMC | Horse Racing Free Tips

Weekly Stewards And Commissions Rulings, June 27-July 3

Every week, the TDN publishes a roundup of key official rulings from the primary tracks within the four major racing jurisdictions of California, New York, Florida and Kentucky.

Here's a primer on how each of these jurisdictions adjudicates different offenses, what they make public (or not) and where.

The TDN will also post a roundup of the relevant Horseracing Integrity and Safety Act (HISA) related rulings from the same week. These will include decisions from around the country.

New York
Track: Belmont Park
Date: 06/27/2023
Licensee: Manuel Franco, jockey
Penalty: Three-day suspension
Violation: Careless riding
Explainer: For having waived his right to an appeal Jockey Mr. Manuel Franco is hereby suspended (3) NYRA racing days July 7th 2023, July 8th 2023, July 9th 2023 inclusive. This for careless riding during the running of the second race at Belmont Park on June 22nd 2023.

NEW HISA/HIWU STEWARDS RULINGS
The following rulings were reported on HISA's “rulings” portal and through the Horseracing Integrity & Welfare Unit's “pending” and “resolved” cases portals.
This does not include the voided claim rulings which were sent to the TDN directly. Some of these rulings are from prior weeks as they were not reported contemporaneously.
One important note: HISA's whip use limit is restricted to six strikes during a race.

Violations of Crop Rule
Belterra Park
William Vernon Bush – violation date June 29; $500 fine and one-day suspension, 13 strikes

Los Alamitos
Tiago Pereira – violation date June 25; $250 fine and one-day suspension, 7 strikes
Abel Cedillo – violation date July 1; $250 fine and one-day suspension, 7 strikes
Erick Garcia – violation date July 1; $250 fine and one-day suspension, 7 strikes
Cesar Ortega – violation date July 2; $250 fine and one-day suspension, 7 strikes
Edgar Payeras – violation date July 2; $250 fine and one-day suspension, 7 strikes

Pending ADMC Violations
Date: 06/09/2023
Licensee: Douglas Nunn, trainer
Penalty: Pending
Alleged violation: Intra-articular Injection violation
Explainer: For the use of an intra-articular injection on Smithwick's Spice, who won at Delaware Park on 6/9/23, within 14 days prior to Post-Time. This is a possible violation of Rule 3313—Use of a Controlled Medication Method in relation to a Covered Horse during the Race Period. This is also a possible violation of Rule 4222—Intra-articular Injection within 14 days prior to Post-Time.

Date: 06/04/2023
Licensee: McLean Robertson, trainer
Penalty: Provisional suspension
Alleged violation: Medication violation
Explainer: For the presence of Altrenogest—a banned substance—in a sample taken from Johnny Up, who won at Canterbury Park on 6/4/23. This is a possible violation of Rule 3212—Presence of a Banned Substance and/or its Metabolites or Markers.
Read more on the story here.

Date: 06/01/2023
Licensee: Jonathon Wong, trainer
Penalty: Provisional suspension
Alleged violation: Medication violation
Explainer: For the presence of Metformin—a banned substance—in a sample taken from Heaven and Earth, who won at Horseshoe Indianapolis on 6/1/23. This is a possible violation of Rule 3212—Presence of a Banned Substance and/or its Metabolites or Markers.
Read more on the story here.

Date: 05/28/2023
Licensee: Ricardo Legall, trainer
Penalty: Pending
Alleged violation: Medication violations
Explainer: For the presence of Levamisole—Controlled Medication (Class B)—in a sample taken from Merchants of Cool, who finished fifth at Belmont Park on 5/28/23. This is a possible violation of Rule 3312—Presence of Controlled Medication Substance and/or its Metabolites or Markers.
For the presence of Dimethylsulfoxide—Controlled Medication (Class C)—in a sample taken from Merchants of Cool, who finished fifth at Belmont Park on 5/28/23. This is a possible violation of Rule 3312—Presence of Controlled Medication Substance and/or its Metabolites or Markers.

Date: 05/28/2023
Licensee: Ray Handal, trainer
Penalty: Pending
Alleged violation: Medication violation
Explainer: For the presence of Zeranol—a banned substance—in a sample taken from Barrage, who finished second at Belmont Park on 5/28/23. This is a possible violation of Rule 3212—Presence of a Banned Substance and/or its Metabolites or Markers. Pursuant to ADMC Program Rule 3247(e), HIWU has lifted the Provisional Suspension based upon information submitted by the Covered Person and the review of relevant scientific information. The Equine Anti-Doping Notice has not been withdrawn.
Read more on the story here.

The post Weekly Stewards And Commissions Rulings, June 27-July 3 appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Study Confirms Hair Use For Long-Term Detection Of Bisphosphonates

A new study, called for in 2019 by the Grayson-Jockey Club Research Foundation, was published on the use of hair as a matrix for the long-term detection of bisphosphonates in horses, the organization said in a release Thursday.

“Over the past few years, bisphosphonate use has become a concern with regard to the welfare of Thoroughbred racehorses,” said Jamie Haydon, president of Grayson. “We are very thankful for the generous support by Vinnie and Teresa Viola's St. Elias Stables and their ability to recognize the importance of this research in promoting equine safety and welfare.”

The new study found that hair testing can be used to consistently detect bisphosphonates for up to six months after administration.

“Bisphosphonates are labeled for horses 4 years and older to manage navicular symptoms,” said Dr. Johnny Smith, A. Gary Lavin Research Chair of Grayson. “Unfortunately, people were using them in young horses, which is detrimental because bisphosphonates inhibit bone resorption, can stay in a horse's system for years, and can have long-term effects on bone.”

Previously published studies, including one conducted by the same group and funded under the same special call, demonstrated that in some cases bisphosphonates can be detected in blood and urine for extended periods of time, but detection using these matrices can be unpredictable and less consistent.

“Our study from 2020 showed that clodronate and tiludronate reside in the bone for extended periods,” said the study's principal investigator, Dr. Heather K. Knych, who is with the K.L. Maddy Equine Analytical Chemistry Lab's Pharmacology section and the Department of Molecular Biosciences, at the School of Veterinary Medicine, University of California, Davis. “This can lead to lasting pharmacologic effects and increase the risks of injury to racehorses. Being able to detect bisphosphonates long term in hair benefits the athletes and increases the integrity of the sport.”

Bisphosphonates are considered a banned substance for covered horses under the Horseracing Integrity and Safety Authority's Anti-Doping and Medication Control program. A covered horse that tests positive is subject to lifetime ineligibility.

Click here to read the study.

The post Study Confirms Hair Use For Long-Term Detection Of Bisphosphonates appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

One Month In, HIWU Issues an Update

From the desk of Ben Mosier, Executive Director, Horseracing Integrity & Welfare Unit (HIWU):

The last four weeks have represented the culmination of more than a year of planning and countless hours of preparation by the HIWU team to put forth the best national Anti-Doping and Medication Control (ADMC) Program possible for Thoroughbred racing. It has been incredibly rewarding to see HISA's ADMC Program get off the ground successfully. Through Sunday, June 18, HIWU-trained and certified sample collection personnel have collected samples from over 6,500 horses from more than 20 tracks nationwide. The samples are being analyzed by one of six approved laboratories, which are all testing for the same substances at the same levels. Furthermore, our anonymous whistleblower platforms are active, and our investigative staff have been reviewing the tips submitted to determine further action, when appropriate.

The Belmont Stakes was the first Triple Crown race to be conducted under HISA's ADMC Program. More than a dozen members of the HIWU team were on site at Belmont Park to assist operations, which included supporting the local sample collection personnel and investigators. The New York Racing Association (NYRA) has been a great partner with us, and we appreciate their collaboration to help make this historic race a success.

With our first month of enforcement now complete, I would like to remind industry participants that HIWU must follow specific public disclosure requirements when there are violations of the ADMC Program. In the case of a positive test for a Banned Substance, HIWU must publish the violation on our website upon the imposition of Provisional Suspensions to the Covered Person and Covered Horse. This will occur after HIWU receives the positive test result for the A Sample. For a positive test associated with a Controlled Medication, the violation will be published once the B Sample confirms the positive test or the Covered Person waives the right to test the B Sample. Non-presence cases (i.e., cases not involving a positive test) will be published after a Provisional Suspension is imposed on the Covered Person or a Charge Letter is served, whichever is earlier.

We expect that most cases will be public within weeks and resolved within a few months, which will be a welcome change from previous protocols.

HIWU recognizes the importance of continually offering education opportunities to help facilitate compliance among those impacted by the ADMC Program. In addition to HIWU's Education & Resources page, our team is available to meet with stakeholders and/or industry groups in person or virtually. Groups who would like to request a meeting should contact Stephanie Jenson at sjenson@hiwu.org.

With our busiest months still to come, my team and I are excited to continue enforcement across the country and to maintain our relationships with the stakeholders who have made our efforts possible, from state racing commissions, racetracks, and laboratories to horsemen, veterinarians, and stewards. I am confident that this Program will ultimately enhance the health and safety of our equine and human athletes while promoting a level playing field that benefits the sport's honest participants.

The post One Month In, HIWU Issues an Update appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

HISA’s Lasix Advisory Committee Set

Edited Press Release

The Horseracing Integrity and Safety Authority (HISA) announced the members of an Advisory Committee which has been convened to oversee a three-year study on the use of furosemide (also known as “Lasix”) on horses during the 48-hour period before the start of a Covered Horserace, including the effect on equine health and the integrity of competition.

The establishment of this Advisory Committee for the study of furosemide administration and the requirements of the study are specifically mandated and set forth in the Horseracing Integrity and Safety Act. The HISA Board of Directors delegated its authority to select the Advisory Committee members to HISA's Anti-Doping and Medication Control (ADMC) Committee who did so based on the members' relevant expertise. The Advisory Committee will oversee the process of issuing a Request for Proposal to conduct the research, reviewing grant applications from academic researchers and allocating grant funding for the study.

When the independent scientific research has been completed and published, it will be presented to the Advisory Committee who will then relay the findings and their recommendations to the HISA Board of Directors.

The Furosemide Advisory Committee is comprised of the following members:

Emma Adam, DVM, Ph.D., is a veterinarian with over 24 years of racing experience in the United States, United Kingdom, France and Australia. She is board-certified in equine medicine from Texas A&M University and in surgery from the New Bolton Center at the University of Pennsylvania. Dr. Adam also received her Ph.D. in musculoskeletal science from the University of Kentucky's Gluck Equine Research Center.
Alan Foreman is Chairman of the Thoroughbred Horsemen's Association (THA) and Vice-Chairman of the Racing Medication and Testing Consortium (RMTC). Foreman is considered one of the leading racing law and equine attorneys in the United States and is an expert on medications used in horse racing.
Scott Hay, DVM, is a veterinarian at Teigland, Franklin and Brokken, where he focuses on lameness, performance evaluations and purchase examinations. He also serves on the RMTC's Scientific Advisory Committee. Dr. Hay previously served as President of the American Association of Equine Practitioners (AAEP) and as a member of the Grayson-Jockey Club's Scientific Advisory Committee.
Ted Hill, VMD, is a racing steward for The Jockey Club with more than 23 years of experience. He previously served as Chief Veterinarian for the New York Racing Association (NYRA). Dr. Hill received his VMD from the University of Pennsylvania.
Rob Holland, DVM, Ph.D., is a respiratory and infectious disease specialist in Lexington, Kentucky and partner at Holland Management Services, Inc., a consulting practice offering solutions in outcomes research and veterinary medicine. Dr. Holland has worked with the Kentucky Horse Racing Commission (KHRC) and is an expert in equine drug testing processes.
Heather Knych, DVM, Ph.D., DACVCP, is a Professor of Clinical Veterinary Pharmacology and Head of the Pharmacology Section at the K.L. Maddy Equine Analytical Chemistry Pharmacology Laboratory at the School of Veterinary Medicine at the University of California, Davis. Dr. Kynch is board-certified in Clinical Veterinary Pharmacology and has an extensive publication record in the areas of pharmacokinetics and pharmacodynamics. She received her DVM and Ph.D. in Pharmacology and Toxicology from the University of California, Davis, where she also conducted her residency in Veterinary Pharmacology.
Ryan Murphy is the Executive Director for the Partnership for Clean Competition (PCC), the leading anti-doping research organization dedicated to the protection of clean athletes. Prior to joining the PCC, Murphy served as Program Officer with the Sports Diplomacy division at the U.S. Department of State and prior to that as Senior Manager for Sport & Competition for Special Olympics International. Murphy has also worked as an International Doping Control Officer for International Doping Tests & Management. In addition to his work at the PCC, Murphy serves as an Adjunct Professor for the Sports Industry Management Master's program at Georgetown University.
Foster Northrop, DVM, is a practicing racetrack veterinarian with more than 35 years of industry experience. He has served on the boards of the KHRC and American Veterinary Medical Association (AVMA), as well as the RMTC's Scientific Advisory Committee.
Scott Palmer, VMD, is a former President of the AAEP and the American Board of Veterinary Practitioners (ABVP). He also chaired the New York Task Force for Racehorse Health and Safety from 2011 to 2013 and served as a clinician and referral surgeon at the New Jersey Equine Clinic for 38 years. He is currently a member of the RMTC's Scientific Advisory Committee, the Horseracing Testing Laboratory Committee, the Association of Racing Commissioners International's (ARCI) Drug Testing and Standards Committee and the ARCI's Equine Welfare and Veterinarians Committee.
N. Edward Robinson, BVetMed, Ph.D., is a nationally recognized veterinarian, academic and researcher who spent nearly 50 years at Michigan State University's College of Veterinary Medicine, during which he spent more than 20 years as the Matilda R. Wilson Professor of Large Animal Clinical Sciences. Dr. Robinson has spent his career researching lung disease in horses. He received his veterinary degree from the Royal Veterinary College in London and a Ph.D. from University of California, Davis.
Corinne Sweeney, DVM (HIWU Appointment), is an American College of Veterinary Internal Medicine (ACVIM) specialist and has spent the past 44 years at the University of Pennsylvania School of Veterinary Medicine. She has served as a member of the Pennsylvania State Horse Racing Commission since 2008 and previously served as Chair of the ARCI in 2019. She is a certified Organizational Ombuds Practitioner and has served as the Penn Vet Ombuds since 2015.

The post HISA’s Lasix Advisory Committee Set appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post